About Cytotoxic and regulatory T-cell molecule
Cytotoxic and regulatory T-cell molecule (CRTAM) is a protein
from Homo sapiens identified by UniProt accession
O95727, 393 residues long.
MolForge cross-references it against 0 known binders and
166 disease associations.
Target properties
| Protein name | Cytotoxic and regulatory T-cell molecule |
| UniProt accession | O95727 |
| Gene | CRTAM |
| Organism | Homo sapiens |
| Length | 393 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (166)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.42
- age at menarche · score 0.33
- IGF-1 measurement · score 0.29
- testosterone measurement · score 0.21
- pancreatic adenocarcinoma · score 0.18
- insulin like growth factor measurement · score 0.15
- FEV/FVC ratio · score 0.14
- hematocrit · score 0.11
- C-reactive protein measurement · score 0.10
- inflammatory biomarker measurement · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95727-F1 | alphafold | PREDICTED | 73.52 | — |
Amino-acid sequence (393 residues)
MWWRVLSLLA WFPLQEASLT NHTETITVEE GQTLTLKCVT SLRKNSSLQW LTPSGFTIFL NEYPALKNSK YQLLHHSANQ LSITVPNVTL QDEGVYKCLH YSDSVSTKEV KVIVLATPFK PILEASVIRK QNGEEHVVLM CSTMRSKPPP QITWLLGNSM EVSGGTLHEF ETDGKKCNTT STLIIHTYGK NSTVDCIIRH RGLQGRKLVA PFRFEDLVTD EETASDALER NSLSSQDPQQ PTSTVSVTED SSTSEIDKEE KEQTTQDPDL TTEANPQYLG LARKKSGILL LTLVSFLIFI LFIIVQLFIM KLRKAHVIWK KENEVSEHTL ESYRSRSNNE ETSSEEKNGQ SSHPMRCMNY ITKLYSEAKT KRKENVQHSK LEEKHIQVPE SIV
Explore Cytotoxic and regulatory T-cell molecule with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets